Nachega JB - Search Results

1

Better Virological Outcomes Among People Living With Human Immunodeficiency Virus (HIV) Initiating Early Antiretroviral Treatment (CD4 Counts ≥500 Cells/µL) in the HIV Prevention Trials Network 071 (PopART) Trial in South Africa.

Fatti G, Grimwood A, Nachega JB, Nelson JA, LaSorda K, van Zyl G, Grobbelaar N, Ayles H, Hayes R, Beyers N, Fidler S, Bock P. Fatti G, et al. Among authors: nachega jb. Clin Infect Dis. 2020 Jan 16;70(3):395-403. doi: 10.1093/cid/ciz214. Clin Infect Dis. 2020. PMID: 30877753 Free PMC article. Clinical Trial.

2

Tuberculosis drug resistance: a global threat.

Nachega JB, Chaisson RE. Nachega JB, et al. Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S24-30. doi: 10.1086/344657. Clin Infect Dis. 2003. PMID: 12516027

3

Adherence to antiretroviral therapy in HIV-infected adults in Soweto, South Africa.

Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. Nachega JB, et al. AIDS Res Hum Retroviruses. 2004 Oct;20(10):1053-6. doi: 10.1089/aid.2004.20.1053. AIDS Res Hum Retroviruses. 2004. PMID: 15585095

4

HIV/AIDS and antiretroviral treatment knowledge, attitudes, beliefs, and practices in HIV-infected adults in Soweto, South Africa.

Nachega JB, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, Karstaedt AS. Nachega JB, et al. J Acquir Immune Defic Syndr. 2005 Feb 1;38(2):196-201. doi: 10.1097/00126334-200502010-00011. J Acquir Immune Defic Syndr. 2005. PMID: 15671805

5

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G. Nachega JB, et al. J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84. doi: 10.1097/01.qai.0000225015.43266.46. J Acquir Immune Defic Syndr. 2006. PMID: 16878045

6

Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study.

Nachega JB, Knowlton AR, Deluca A, Schoeman JH, Watkinson L, Efron A, Chaisson RE, Maartens G. Nachega JB, et al. J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S127-33. doi: 10.1097/01.qai.0000248349.25630.3d. J Acquir Immune Defic Syndr. 2006. PMID: 17133196

7

Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.

Nachega JB, Hislop M, Dowdy DW, Chaisson RE, Regensberg L, Maartens G. Nachega JB, et al. Ann Intern Med. 2007 Apr 17;146(8):564-73. doi: 10.7326/0003-4819-146-8-200704170-00007. Ann Intern Med. 2007. PMID: 17438315

8

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB. Bisson GP, et al. Among authors: nachega jb. PLoS Med. 2008 May 20;5(5):e109. doi: 10.1371/journal.pmed.0050109. PLoS Med. 2008. PMID: 18494555 Free PMC article.

9

Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults.

Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, Maartens G. Nachega JB, et al. AIDS. 2008 Oct 18;22(16):2117-25. doi: 10.1097/QAD.0b013e328310407e. AIDS. 2008. PMID: 18832875 Free PMC article.

10

Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa.

Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, Cotton M, Maartens G. Nachega JB, et al. J Acquir Immune Defic Syndr. 2009 May 1;51(1):65-71. doi: 10.1097/QAI.0b013e318199072e. J Acquir Immune Defic Syndr. 2009. PMID: 19282780 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

246 results

Search Page

Filters